{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T17:12:20Z","timestamp":1771866740241,"version":"3.50.1"},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2015,11,11]],"date-time":"2015-11-11T00:00:00Z","timestamp":1447200000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0142205","type":"journal-article","created":{"date-parts":[[2015,11,11]],"date-time":"2015-11-11T13:53:59Z","timestamp":1447250039000},"page":"e0142205","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":43,"title":["A Retrospective Longitudinal Within-Subject Risk Interval Analysis of Immunoglobulin Treatment for Recurrent Acute Exacerbation of Chronic Obstructive Pulmonary Disease"],"prefix":"10.1371","volume":"10","author":[{"given":"Juthaporn","family":"Cowan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Logan","family":"Gaudet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunita","family":"Mulpuru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicente","family":"Corrales-Medina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Hawken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shawn D.","family":"Aaron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. William","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,11,11]]},"reference":[{"issue":"6","key":"ref1","first-page":"1","article-title":"Deaths: preliminary data for 2011","volume":"61","author":"DL Hoyert","year":"2012","journal-title":"Natl Vital Stat Rep"},{"issue":"5","key":"ref2","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1164\/ajrccm.157.5.9709032","article-title":"Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease","volume":"157","author":"TA Seemungal","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"ref3","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1136\/thx.2005.040527","article-title":"Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease","volume":"60","author":"JJ Soler-Cataluna","year":"2005","journal-title":"Thorax"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1513\/AnnalsATS.201208-043OC","article-title":"Predictors of mortality in hospitalized adults with acute exacerbation of chronic obstructive pulmonary disease","volume":"10","author":"A Singanayagam","year":"2013","journal-title":"Ann Am Thorac Soc"},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1164\/rccm.201211-2044OC","article-title":"Quantifying health services use for chronic obstructive pulmonary disease","volume":"187","author":"AS Gershon","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3109\/15412555.2010.481697","article-title":"The economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a review","volume":"7","author":"EL Toy","year":"2010","journal-title":"COPD"},{"issue":"6","key":"ref7","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1183\/09031936.04.00014304","article-title":"Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS\/ERS position paper","volume":"23","author":"BR Celli","year":"2004","journal-title":"Eur Respir J"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S2213-2600(14)70163-8","article-title":"Why doesn&apos;t reducing exacerbations decrease COPD mortality?","volume":"2","author":"G Brussele","year":"2014","journal-title":"Lancet Respir Med"},{"issue":"26","key":"ref9","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1056\/NEJMoa032158","article-title":"The nature of small-airway obstruction in chronic obstructive pulmonary disease","volume":"350","author":"JC Hogg","year":"2004","journal-title":"N Engl J Med"},{"issue":"9589","key":"ref10","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(07)61382-8","article-title":"COPD exacerbations: defining their cause and prevention","volume":"370","author":"JA Wedzicha","year":"2007","journal-title":"Lancet"},{"issue":"9","key":"ref11","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1164\/rccm.200607-995OC","article-title":"The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease","volume":"175","author":"SI Rennard","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000117386","article-title":"Effect of infliximab on local and systemic inflammation in chronic obstructive pulmonary disease: a pilot study","volume":"76","author":"MA Dentener","year":"2008","journal-title":"Respiration"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/thoraxjnl-2012-202432","article-title":"TNFalpha antagonists for acute exacerbations of COPD: a randomised double-blind controlled trial","volume":"68","author":"SD Aaron","year":"2013","journal-title":"Thorax"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1378\/chest.122.1.289","article-title":"A randomized, placebo-controlled trial of a leukotriene synthesis inhibitor in patients with COPD","volume":"122","author":"S Gompertz","year":"2002","journal-title":"Chest"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.rmed.2004.09.008","article-title":"Short-term effects of montelukast in stable patients with moderate to severe COPD","volume":"99","author":"P Celik","year":"2005","journal-title":"Respir Med"},{"issue":"9","key":"ref16","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/j.1365-2222.2012.03979.x","article-title":"Long-term macrolide treatment of chronic inflammatory airway diseases: risks, benefits and future developments","volume":"42","author":"EJ Cameron","year":"2012","journal-title":"Clin Exp Allergy"},{"issue":"8","key":"ref17","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa1104623","article-title":"Azithromycin for prevention of exacerbations of COPD","volume":"365","author":"RK Albert","year":"2011","journal-title":"N Engl J Med"},{"issue":"11","key":"ref18","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa040582","article-title":"Oral erythromycin and the risk of sudden death from cardiac causes","volume":"351","author":"WA Ray","year":"2004","journal-title":"N Engl J Med"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/jac\/dkl014","article-title":"Macrolide resistance of Staphylococcus aureus and Haemophilus species associated with long-term azithromycin use in cystic fibrosis","volume":"57","author":"SJ Phaff","year":"2006","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s10156-009-0021-4","article-title":"Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia","volume":"16","author":"M Morozumi","year":"2010","journal-title":"J Infect Chemother"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1513\/pats.201102-016RM","article-title":"Pharmacotherapeutic approaches to preventing acute exacerbations of chronic obstructive pulmonary disease","volume":"8","author":"MK Han","year":"2011","journal-title":"Proc Am Thorac Soc"},{"issue":"11","key":"ref22","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S2213-2600(14)70187-0","article-title":"Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study","volume":"2","author":"CE Brightling","year":"2014","journal-title":"Lancet Respir Med"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000064258","article-title":"Hypogammaglobulinemia in steroid-dependent asthmatics correlates with the daily dose of oral prednisolone","volume":"128","author":"T Kawano","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"issue":"8","key":"ref24","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1164\/rccm.200510-1609OC","article-title":"Immunoglobulin G levels before and after lung transplantation","volume":"173","author":"NH Yip","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"ref25","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMra993360","article-title":"Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin","volume":"345","author":"MD Kazatchkine","year":"2001","journal-title":"N Engl J Med"},{"issue":"5447","key":"ref26","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1126\/science.286.5447.2156","article-title":"Control of early viral and bacterial distribution and disease by natural antibodies","volume":"286","author":"AF Ochsenbein","year":"1999","journal-title":"Science"},{"issue":"21","key":"ref27","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1056\/NEJMra1009433","article-title":"Intravenous immune globulin in autoimmune and inflammatory diseases","volume":"367","author":"EW Gelfand","year":"2012","journal-title":"N Engl J Med"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1503\/cmaj.130375","article-title":"Intravenous immunoglobulin as clinical immune-modulating therapy","volume":"187","author":"L Gilardin","year":"2015","journal-title":"CMAJ"},{"issue":"12","key":"ref29","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1136\/thoraxjnl-2013-203773","article-title":"The yin and the yang of immunosuppression with inhaled corticosteroids","volume":"68","author":"I Sabroe","year":"2013","journal-title":"Thorax"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S1081-1206(10)61380-4","article-title":"Effects of long-term low-dose corticosteroid therapy on humoral immunity","volume":"97","author":"ME Fedor","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"ref31","first-page":"281","article-title":"Role of immunoglobulin in treating chronic obstructive pulmonary disease with fungal infection","volume":"13","author":"JR Zhu","year":"2014","journal-title":"Chin Infect Control"},{"issue":"15\u201316","key":"ref32","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1016\/j.vaccine.2004.01.017","article-title":"Control without separate controls: evaluation of vaccine safety using case-only methods","volume":"22","author":"CP Farrington","year":"2004","journal-title":"Vaccine"},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ejcdt.2012.07.001","article-title":"Bronchiectasis in COPD patients","volume":"61","author":"EO Arram","year":"2012","journal-title":"Egyptian Journal of Chest Diseases and Tuberculosis"},{"issue":"12","key":"ref34","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","article-title":"Susceptibility to exacerbation in chronic obstructive pulmonary disease","volume":"363","author":"JR Hurst","year":"2010","journal-title":"N Engl J Med"},{"issue":"3","key":"ref35","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.rmed.2007.10.010","article-title":"The cost of moderate and severe COPD exacerbations to the Canadian healthcare system","volume":"102","author":"N Mittmann","year":"2008","journal-title":"Respir Med"},{"key":"ref36","unstructured":"Quality-Based Procedures: Clinical Handbook for Chronic Obstructive Pulmonary Disease\u2014qbp_copd.pdf. Available at: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/health.gov.on.ca\/en\/pro\/programs\/ecfa\/docs\/qbp_copd.pdf\" xlink:type=\"simple\">http:\/\/health.gov.on.ca\/en\/pro\/programs\/ecfa\/docs\/qbp_copd.pdf<\/ext-link>. Accessed 6\/30\/2015, 2015."},{"issue":"10","key":"ref37","doi-asserted-by":"crossref","first-page":"e75199","DOI":"10.1371\/journal.pone.0075199","article-title":"IVIg immune reconstitution treatment alleviates the state of persistent immune activation and suppressed CD4 T cell counts in CVID","volume":"8","author":"D Paquin-Proulx","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/08923973.2013.864668","article-title":"Dose-related regulatory effect of intravenous immunoglobulin on dendritic cells-mediated immune response","volume":"36","author":"J Qian","year":"2014","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"2","key":"ref39","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.clim.2011.01.002","article-title":"Preparations of intravenous immunoglobulins diminish the number and proinflammatory response of CD14+CD16++ monocytes in common variable immunodeficiency (CVID) patients","volume":"139","author":"M Siedlar","year":"2011","journal-title":"Clin Immunol"},{"issue":"7354","key":"ref40","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature10134","article-title":"Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway","volume":"475","author":"RM Anthony","year":"2011","journal-title":"Nature"},{"issue":"5874","key":"ref41","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.1154315","article-title":"Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc","volume":"320","author":"RM Anthony","year":"2008","journal-title":"Science"},{"issue":"9","key":"ref42","doi-asserted-by":"crossref","first-page":"E24","DOI":"10.1073\/pnas.0900016106","article-title":"DC-SIGN and alpha2,6-sialylated IgG Fc interaction is dispensable for the anti-inflammatory activity of IVIg on human dendritic cells","volume":"106","author":"J Bayry","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref43","article-title":"The Expanding Role of Therapeutic Antibodies","author":"S Salemi","year":"2014","journal-title":"Int Rev Immunol"},{"issue":"4","key":"ref44","first-page":"235","article-title":"Viral infections as a cause of chronic obstructive pulmonary disease (COPD) exacerbation","volume":"99","author":"O Kherad","year":"2010","journal-title":"Praxis (Bern 1994)"},{"issue":"4","key":"ref45","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrmicro3231","article-title":"The co-pathogenesis of influenza viruses with bacteria in the lung","volume":"12","author":"JA McCullers","year":"2014","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"ref46","first-page":"373","article-title":"Humoral immunodeficiency in recurrent upper respiratory tract infections. Some basic, clinical and therapeutic features","volume":"54","author":"J Daele","year":"2000","journal-title":"Acta Otorhinolaryngol Belg"},{"issue":"2","key":"ref47","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1586\/1744666X.1.2.213","article-title":"Natural autoantibodies: immune homeostasis and therapeutic intervention","volume":"1","author":"J Bayry","year":"2005","journal-title":"Expert Rev Clin Immunol"},{"issue":"Suppl 4","key":"ref48","doi-asserted-by":"crossref","first-page":"S217","DOI":"10.1007\/s10072-003-0081-7","article-title":"Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases","volume":"24","author":"J Bayry","year":"2003","journal-title":"Neurol Sci"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0142205","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T21:57:16Z","timestamp":1540331836000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0142205"}},"subtitle":[],"editor":[{"given":"Chunxue","family":"Bai","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,11,11]]},"references-count":48,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2015,11,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0142205","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,11]]}}}